See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583107_2023_Theravance_Biopharma_Inc.pdf
Logs
Graph
Absolute values for 0001583107, Theravance Biopharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 353,464,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,875,000 |
| 3 | remainder_Assets | 242,061,000 |
| 4 | LiabilitiesCurrent | 28,715,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 55,962,448 |
| 9 | ResearchAndDevelopmentExpense | 58,623,810 |
| 10 | remainder_Expenses | 41,784,130 |
| 11 | remainder_Revenues | 51,729,345 |
| 12 | remainder_NetIncome | 5,290,056,265 |
| 13 | remainder_ComprehensiveNetIncome | -22,988 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 607,400,000 |
| 1 | Liabilities | 28,715,000 |
| 2 | Expenses | 156,370,388 |
| 3 | Revenues | 51,729,345 |
| 4 | StockholdersEquity | 578,685,000 |
| 5 | NetIncome | 5,185,415,222 |
| 6 | ComprehensiveNetIncome | 5,185,403,728 |
| 7 | BaseVar | 3,067,146,993 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 20.3 |
| 9 | EconomicCapitalRatio | 20.3 |
Edgar->Model Mapping
Feature Distribution
Change over Time
